Voloznev Lion

Voloznev Lion

Lev Voloznev is the director of chemical and pharmaceutical department of Rusatom Healthcare of Rosatom state corporation. The expert at the Moscow school of management Skolkovo in a pharmakoekonomika and social demographically the analysis in health care.

Biography

As of 2017 working experience of Lev Voloznev in the field of nuclear medicine — more than 9 years.

The biophysicist by training, has the degree of Candidate of Biology received at department of radiobiology MGAVMIB by him K.I. Scriabina in a radiobiology.

Started the career in 2010 as the assistant to medical department of the pharmaceutical enterprise of a full stroke of JSC Pharm-Sintez which is the developer and producer of high-tech medicines for oncology, surgery, nuclear medicine, gynecology, neurology.

Later held a position of the director of development of the medicines "Pharm-Sintez" where the area of responsibility included work on management of developments of medicines and also a post of the CEO of Pharm-Sintez Lab LLC which is engaged in developments of analytical methods of quality control and production technologies, synthesis of organic and peptide pharmaceutical substances, precursors for a positron emission tomography and radio nuclide therapy including their commercialization.

On November 27, 2017 Lev Voloznev joined the Rusatom Healthcare command (AO RHK) of Rosatom state corporation as the director of chemical and pharmaceutical department. Submits to the CEO of RHK Denis Cherednichenko. In Rusatom Healthcare Lev Voloznev will be responsible for development of the block of chemical and pharmaceutical production of medicines and medical products for nuclear medicine.^[1]

As of 2017, is the expert at the Moscow school of management Skolkovo in a pharmakoekonomika and social demographically the analysis in health care.

Notes